查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495947

颅内动脉瘤市场 – 2024 年至 2029 年预测

Intracranial Aneurysm Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

颅内动脉瘤市场预计将以 8.41% 的复合年增长率成长，从 2022 年的 14.11 亿美元成长到 2029 年的 24.84 亿美元。

脑动脉瘤（也称为脑动脉瘤或颅内动脉瘤）是一种气球状动脉瘤，由大脑动脉壁的薄弱点发展而来。蛛网膜下腔出血 (SAH) 是指大脑周围出血，当动脉变得「水泡状」增大、变细并突然破裂时，就会发生这种情况。

这种出血可能导致中风、失去知觉，甚至死亡。动脉瘤的大小仅为约 1/8 英吋至 1 英吋。巨大动脉瘤很难治疗，如果大于 1 英寸，则会带来特别严重的风险。

颅内动脉瘤市场的成长机会

预计在预测期内，脑动脉瘤的盛行率将会增加，微创颅内动脉瘤手术预计将刺激颅内动脉瘤产业的发展。颅内动脉瘤导致脑动脉壁隆起。它可能会肿胀、扩散或非自然出血。

形成脑动脉瘤的危险因子包括吸烟、高血压、血管创伤、遗传脆弱性和血管损伤。脑动脉瘤的治疗包括药物治疗、手术夹闭、血管内治疗、以及单独或与辅助器具组合的弹簧圈栓塞。

老年人口增加

颅内动脉瘤市场受到血管创伤和血压过高患者数量不断增加的推动。高血压会显着增加多种疾病的风险，包括脑动脉瘤。由于血压过高和吸烟，很大一部分人面临脑动脉瘤的风险。

根据 NCBI 的调查结果，老年人中未破裂脑动脉瘤的盛行率正在迅速增加，尤其是 70 岁以上的老年人。根据世界卫生组织2022年报告，到2050年，全球60岁及以上的人口将达到35亿，而2019年这一数字为10亿。

微创手术增加

如今，微创手术变得越来越普遍，因为它涉及的风险和创伤较小。较小的切口可减少术后不适并加快癒合速度，从而提高了这些治疗方法的普及，并刺激了该领域的研究和开发。

几个主要参与企业不断投资于研发，以推出尖端的血管内卷取工具。医师强烈建议的微创治疗方法是血管内卷取，用于治疗脑动脉瘤。在该手术中，将微导管放置在含有动脉瘤的腹股沟区域的动脉中。然后取下铂线圈。铂金弹簧圈有助于凝结动脉瘤并阻止血液流向大脑其他部位。

血管内卷取是推进部分

未来，血管内卷取预计将稳定成长。此手术的优点，例如容易进入脊椎骨系统、偏远位置的大量动脉瘤以及比其他手术更快的恢復期，正在推动颅内动脉瘤市场的扩张。

此外，全球范围内不断增加的中风数量可能会导致血管破裂并导致脑动脉瘤，从而推动颅内动脉瘤市场的收益扩张。例如，世界中风组织 (WSO) 报告称，2022 年将有大约 1,200 万人 (12,224,551) 患有中风。

不断上升的研发与技术突破

由于颅内动脉瘤治疗的研发力度加大、医疗设施的改善、颅内动脉瘤诊断和治疗新疗法的技术进步、行业研发的增长以及日常医疗投资的增加，颅内动脉瘤行业正在蓬勃发展。预计在预测期内将经历有利的成长机会。

例如，歌德大学神经病学和神经外科係正在对未破裂脑动脉瘤患者进行第 3 期临床研究，研究乙酰水杨酸和积极血压管理的组合。

越来越多地使用诊断影像技术来支持颅内动脉瘤市场

脑动脉瘤的诊断在很大程度上依赖三种影像方式：磁振造影血管造影术（MRA）、电脑断层扫描（CTA）和动脉内数位减影血管造影术（IADSA）。 CTA 是一种非传统血管摄影技术，在进行常规电脑断层扫描的同时，透过静脉注射显影剂。

目前，识别颅内动脉瘤的黄金标准是IADSA。此外，医生正在使用动脉内数位减影血管造影术来治疗颅内动脉瘤患者。因此，推动颅内动脉瘤市场的原因之一是为颅内动脉瘤的治疗提供优质影像的显像模式。

预计将受到北美颅内动脉瘤市场的推动

由于其完善的医疗基础设施、人口老化以及高血压和中风的高发病率，预计北美将引领颅内动脉瘤市场，并占据重要的收益占有率。

此外，脑动脉瘤发生率的上升和对微创手术的需求正在推动该地区颅内动脉瘤市场的扩张。预计各个组织计划的增加也将促进颅内动脉瘤市场的扩张。例如，蜜蜂基金会 (TBF) 致力于透过前沿研究提高人们对脑动脉瘤的认识并减少脑动脉瘤造成的死亡人数。

亚太地区预计将成为第二大成长市场

亚太地区颅内动脉瘤产业预计将成长。这是由于人口老化、生活方式压力众多、高血压盛行率不断上升、诊断品质提高以及患者负担减轻。

由于上述所有变量，亚太地区的脑动脉瘤手术显着增加。此外，中国、印度和日本等新兴国家诱人的市场开拓前景可能有助于该地区颅内动脉瘤市场的扩张。例如，印度医疗旅游的增加预计将提振市场，因为与美国等已开发国家相比，颅内手术的成本相对较低。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行概述

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章颅内动脉瘤市场：依类型

  • 介绍
  • 手术夹闭
  • 血管内弹簧圈栓塞术
  • 分流器
  • 其他的

第六章颅内动脉瘤市场：依诊断类型

  • 介绍
  • 电脑断层扫描
  • MRI
  • 脑血管血管造影术测试
  • 脑脊髓液 (CSF) 分析

第七章颅内动脉瘤市场：依最终用户分类

  • 介绍
  • 医院
  • 诊所
  • 其他的

第八章颅内动脉瘤市场：按地区

  • 介绍
  • 北美洲
  • 南美洲
  • 欧洲
  • 中东/非洲
  • 亚太地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • Mayo Clinic
  • Terumo
  • Medtronic
  • Kaneka
  • Johns Hopkins Medicine
  • Lepu Medical Technology Company
  • Philips
  • Mayfield Clinic
  • J&J MedTech
简介目录
Product Code: KSI061616029

The intracranial aneurysm market is expected to grow at a CAGR of 8.41% from US$1.411 billion in 2022 to US$2.484 billion in 2029.

A brain aneurysm is a ballooning that develops from a weak spot in the wall of a blood artery in the brain (also known as a cerebral aneurysm or an intracranial aneurysm). A subarachnoid hemorrhage (SAH), which causes bleeding into the area around the brain, occurs when the artery develops a "blister-like" dilatation that can thin out and burst suddenly.

Such a hemorrhage may result in a stroke, unconsciousness, or even death. Aneurysms can be anything from a little 1/8 inch and about one inch in size. Giant aneurysms are difficult to cure and pose a particularly significant danger if they are greater than one inch.

Market growth opportunities for the intracranial aneurysm market

The prevalence of brain aneurysms is expected to increase over the forecast period, and minimally invasive intracranial aneurysm surgeries are expected to be used more frequently fueling the intracranial aneurysm industry. A cerebral artery's wall bulges due to an intracranial aneurysm. An unnatural inflating, widening, or bleb is the outcome.

Risk factors for the occurrence of a brain aneurysm include smoking, hypertension, blood vessel trauma, hereditary vulnerability, and blood vessel damage. Brain aneurysms may be treated with medical therapy, surgical clipping, endovascular therapy, or coiling alone or in combination with auxiliary devices.

Growing geriatric population

The intracranial aneurysm market is being driven by the rising number of patients who have blood vessel trauma and excessive blood pressure. Hypertension significantly raises the risk of several disorders, including brain aneurysms. A significant section of the population is in danger of developing brain aneurysms because of excessive blood pressure and smoking.

Unruptured brain aneurysm prevalence in senior people is rising quickly, especially in those who are 70 years or older, according to NCBI research findings. According to the WHO Report 2022, there will be 3.5 billion people in the globe who are 60 years of age or older by 2050, up from 1 billion in 2019.

Growth in the use of minimally invasive surgeries

Minimally invasive operations are becoming common nowadays due to their lower risk and trauma. Smaller incisions reduce postoperative discomfort and speed up healing, which encourages the widespread use of these treatments and spurs an increase in R&D in the area.

To introduce cutting-edge minimally invasive endovascular coiling tools, several important players are consistently investing in R&D. One of the less invasive treatments that is strongly advised by doctors is the endovascular coiling used to treat cerebral aneurysms. A microcatheter is placed during this surgery through the aneurysm-containing artery in the groyne region. After that, platinum coils are removed since they encourage aneurysm clotting and stop blood flow to other parts of the brain.

Endovascular coiling is a propelling sector

The future is expected to see steady growth for endovascular coiling. The benefits of this operation, including simple access to the vertebrobasilar system, numerous aneurysms in remote locations, and a quicker recovery period than with other procedures, are the reasons driving the intracranial aneurysm market expansion.

Additionally, there is a strong likelihood that the increasing number of strokes occurring globally would rupture blood vessels and cause cerebral aneurysms, which will encourage intracranial aneurysm market revenue growth. For instance, the World Stroke Organization (WSO) reported that in 2022, around 12 million (12,224,551) persons suffered from a stroke.

Growing research and development and technological breakthroughs

With the rise in research and development for the treatment of intracranial aneurysms, improved healthcare facilities, technological advancements in the diagnosis of intracranial aneurysms and the treatment with novel therapeutics, growing research and development in the industry as well as daily increases in healthcare investment, the intracranial aneurysm industry will experience lucrative growth opportunities in the forecast period.

For instance, Acetylsalicylic acid combined with aggressive blood pressure management is being studied in phase 3 clinical investigation at Goethe University's Department of Neurology and Neurosurgery in patients with unruptured cerebral aneurysms.

Increasing the use of imaging techniques to assist the intracranial aneurysm market

The diagnosis of cerebral aneurysms relies heavily on three imaging modalities, magnetic resonance angiography (MRA), computed tomography (CTA), and intra-arterial digital subtraction angiography (IADSA). CTA is a different vascular imaging technique that includes getting a conventional CT scan while receiving an intravenous contrast injection.

The gold standard for identifying intracranial aneurysms at the moment is IADSA. Additionally, medical practitioners use intra-arterial digital subtraction angiography to treat intracranial aneurysm patients. Therefore, one of the reasons propelling the intracranial aneurysm market is imaging modalities that offer superior pictures for the treatment of intracranial aneurysms.

The North American intracranial aneurysm market is projected to propel

North America is anticipated to lead the intracranial aneurysm market and account for a large revenue share due to its established healthcare infrastructure, ageing population, and high rates of hypertension and stroke.

Additionally, a rise in the incidence of cerebral aneurysms and a need for less invasive procedures are fueling intracranial aneurysm market expansion in the area. An increasing number of projects being carried out by various groups is also projected to encourage intracranial aneurysm market expansion. For instance, The Bee Foundation (TBF) is committed to raising awareness and lowering the number of fatalities brought on by brain aneurysms via cutting-edge studies.

Asia Pacific is anticipated to be the second-largest growing market

The Asia Pacific intracranial aneurysm industry is anticipated to grow. This is due to several causes, including an ageing population, numerous lifestyle stressors, an increase in the prevalence of hypertension, better diagnostic quality, and increased patient affordability.

The Asia Pacific region has seen a large increase in cerebral aneurysm surgeries as a result of all the aforementioned variables. Moreover, the expansion of the regional intracranial aneurysm market is likely aided by attractive development prospects in emerging nations like China, India, and Japan. For instance, rising medical tourism to India is anticipated to boost the market because of the comparatively inexpensive cost of intracranial surgery compared to other industrialized nations like the U.S.

Market Key Developments

  • In June 2023, researchers at the RIKEN Centre for Brain Science (CBS) in Japan identified a group of linked mutations that cause intracranial aneurysms weakened blood arteries in the brain that are prone to rupture at any time.
  • In September 2022, Vesalio announced that the NeVa VS has been approved by the Food and Drug Administration to treat cerebral vasospasm following aneurysmal rupture.
  • In June 2022, the first Numen coil embolization treatment and portfolio expansion by Rapid Medical were announced. Rapid Medical and MicroPort NeuroTech, a division of MicroPort Scientific Corporation, have an exclusive distribution arrangement.

Segmentation:

By Type

  • Surgical Clipping
  • Endovascular Coiling
  • Flow Diverters
  • Others

By Diagnosis Type

  • CT scan
  • MRI
  • Cerebral Angiography
  • Cerebrospinal Fluid (CSF) Analysis

By End-User

  • Hospitals
  • Clinics
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits for the stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. INTRACRANIAL ANEURYSM MARKET, BY TYPE

  • 5.1. Introduction
  • 5.2. Surgical Clipping
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Endovascular Coiling
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Flow Diverters
    • 5.4.1. Market Trends and Opportunities
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Others
    • 5.5.1. Market Trends and Opportunities
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness

6. INTRACRANIAL ANEURYSM MARKET, BY DIAGNOSIS TYPE

  • 6.1. Introduction
  • 6.2. CT scan
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. MRI
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Cerebral Angiography
    • 6.4.1. Market Trends and Opportunities
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Cerebrospinal Fluid (CSF) Analysis
    • 6.5.1. Market Trends and Opportunities
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness

7. INTRACRANIAL ANEURYSM MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
    • 7.2.1. Market Trends and Opportunities
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Clinics
    • 7.3.1. Market Trends and Opportunities
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Others
    • 7.4.1. Market Trends and Opportunities
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness

8. INTRACRANIAL ANEURYSM MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Diagnosis Type
    • 8.2.3. By End Users
    • 8.2.4. By Country
      • 8.2.4.1. United States
        • 8.2.4.1.1. Market Trends and Opportunities
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Trends and Opportunities
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Trends and Opportunities
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Diagnosis Type
    • 8.3.3. By End Users
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Trends and Opportunities
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Trends and Opportunities
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Trends and Opportunities
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Diagnosis Type
    • 8.4.3. By End Users
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
        • 8.4.4.1.1. Market Trends and Opportunities
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Trends and Opportunities
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Trends and Opportunities
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Spain
        • 8.4.4.4.1. Market Trends and Opportunities
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Trends and Opportunities
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Diagnosis Type
    • 8.5.3. By End Users
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Trends and Opportunities
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Trends and Opportunities
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Israel
        • 8.5.4.3.1. Market Trends and Opportunities
        • 8.5.4.3.2. Growth Prospects
      • 8.5.4.4. Others
        • 8.5.4.4.1. Market Trends and Opportunities
        • 8.5.4.4.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Diagnosis Type
    • 8.6.3. By End Users
    • 8.6.4. By Country
      • 8.6.4.1. Japan
        • 8.6.4.1.1. Market Trends and Opportunities
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. China
        • 8.6.4.2.1. Market Trends and Opportunities
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Trends and Opportunities
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Trends and Opportunities
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Indonesia
        • 8.6.4.5.1. Market Trends and Opportunities
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Trends and Opportunities
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Others
        • 8.6.4.7.1. Market Trends and Opportunities
        • 8.6.4.7.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Mayo Clinic
  • 10.2. Terumo
  • 10.3. Medtronic
  • 10.4. Kaneka
  • 10.5. Johns Hopkins Medicine
  • 10.6. Lepu Medical Technology Company
  • 10.7. Philips
  • 10.8. Mayfield Clinic
  • 10.9. J&J MedTech